News

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
Three simultaneous withdrawals—from the World Health Organization, USAID and the Gavi vaccine alliance—represent a ...
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...
A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...
The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...
The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...